- Home
- XPEL vs IART Comparison
XPEL vs IART Comparison
Compare XPEL & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XPEL | IART |
|---|---|---|
| Founded | 1999 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 744.3M |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | XPEL | IART |
|---|---|---|
| Price | $38.23 | $9.18 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 256.1K | ★ 750.5K |
| Earning Date | 05-28-2026 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.12 | N/A |
| EPS | ★ 1.85 | N/A |
| Revenue | ★ $476,200,000.00 | N/A |
| Revenue This Year | $12.64 | $4.45 |
| Revenue Next Year | $11.98 | $3.40 |
| P/E Ratio | $21.04 | ★ N/A |
| Revenue Growth | ★ 13.27 | N/A |
| 52 Week Low | $24.27 | $9.26 |
| 52 Week High | $55.91 | $23.27 |
Technical Indicators
Market Signals| Indicator | XPEL | IART |
|---|---|---|
| Relative Strength Index (RSI) | 22.16 | 27.22 |
| Support Level | $35.10 | N/A |
| Resistance Level | $55.36 | $14.14 |
| Average True Range (ATR) | 2.18 | 0.55 |
| MACD | -0.76 | -0.17 |
| Stochastic Oscillator | 5.39 | 7.97 |
Price Performance
Historical ComparisonAbout XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from the sale of automotive products and related services while the remainder of its revenue is derived from non-automotive products including architectural window film and marine and flat surface protection films. The majority of revenue is derived from the United States.
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.